Sudair Pharmaceutical Company
Reema Alzoman is a Regulatory Affairs Specialist at Sudair Pharmaceutical Company, a position held since March 2022, after initially serving in the same role from July 2021 to January 2022. Prior to this, Reema completed an internship at AstraZeneca in April 2021 and gained valuable experience as a PharmD Intern at the Ministry of National Guard Health Affairs from June 2020 to April 2021. Reema's early career includes a brief training period at Al Shafi Pharmacies Co. in July 2019, focusing on over-the-counter medications. Reema holds a Doctor of Pharmacy (PharmD) degree from King Saud bin Abdulaziz University for Health Sciences, obtained in 2021.
Sudair Pharmaceutical Company
1 followers
Sudair pharma is a Saudi-Based company, established in 2014 for purpose of building an advanced pharmaceutical manufacturing complex to combat chronic & life threatening diseases sudair pharma vision is fulfilling the unmet needs in pharmaceutical sector in the Saudi Arabia and MENA region. and also our mission to establishing and localizing Advanced Pharmaceutical-Biologics Industrial Group (APBIG) to improve healthcare provision and the reach to latest pharmaceuticals in Saudi Arabia and MENA region through building a local specialized professional team, international partnership and affiliations. SPC owns the land in Sudair Industrial City (100 km North of Riyadh City) encompassing more than 77,000 square meter. At this manufacturing site, the land will be equitably distributed to major pharmaceutical industry groups as joint ventures to construct manufacturing facilities. sudair pharma project is divided into several stages, first stage which is the establishment of oncology medicine plant.